Literature DB >> 19543877

[Neuro-enhancement from an addiction specialist's viewpoint].

M Soyka1.   

Abstract

The use of medications to enhance performance in healthy individuals is increasingly being propagated even by neuroscientists under such colorful terms as"neuro-enhancement". A large number of medications, including psychostimulants have been advocated in this context. Recent data from the German health insurance company DAK indicate that a number of employees already take medications to fulfill their professional needs and enhance performance. The use of new drugs in the healthy has even been advocated by prominent neurobiologists in a commentary in a recent edition of Nature. There are a number of ethical objections to this use and there is an apparent risk of addiction. To date German psychiatrists have surprisingly not been outspoken on this issue. The author would like to make an emphatic plea against"brain doping" in healthy individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19543877     DOI: 10.1007/s00115-009-2800-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  15 in total

Review 1.  Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).

Authors:  M Rösler; W Retz; J Thome; M Schneider; R-D Stieglitz; P Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09       Impact factor: 5.270

2.  [Identification of pathologic alcohol use and its prevention. Results of employee interviews in a clinic].

Authors:  M Ennenbach; M Soyka
Journal:  Nervenarzt       Date:  2007-05       Impact factor: 1.214

3.  Neuropsychological assessment of adult patients with attention-deficit/hyperactivity disorder.

Authors:  Bernhard W Müller; Karla Gimbel; Anett Keller-Pliessnig; Gudrun Sartory; Markus Gastpar; Eugen Davids
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-01-02       Impact factor: 5.270

Review 4.  Neuroenhancement: status quo and perspectives.

Authors:  Claus Normann; Mathias Berger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

5.  Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication.

Authors:  Ronald C Kessler; Lenard A Adler; Russell Barkley; Joseph Biederman; C Keith Conners; Stephen V Faraone; Laurence L Greenhill; Savina Jaeger; Kristina Secnik; Thomas Spencer; T Bedirhan Ustün; Alan M Zaslavsky
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

6.  Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice.

Authors:  C Clure; K T Brady; M E Saladin; D Johnson; R Waid; M Rittenbury
Journal:  Am J Drug Alcohol Abuse       Date:  1999-08       Impact factor: 3.829

7.  Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence?

Authors:  J Biederman; T E Wilens; E Mick; S V Faraone; T Spencer
Journal:  Biol Psychiatry       Date:  1998-08-15       Impact factor: 13.382

8.  [Effect of subtype and psychiatric comorbidities on methylphenidate treatment in adults with attention-deficit hyperactivity disorder].

Authors:  E Sobanski; B Alm; B Krumm
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

9.  Why should addiction medicine be an attractive field for young physicians?

Authors:  Michael Soyka; David A Gorelick
Journal:  Addiction       Date:  2008-09-04       Impact factor: 6.526

10.  [Amphetamine misuse in suspected adult ADHS syndrome].

Authors:  M Soyka; E Sievers; E Fischer-Erlewein
Journal:  Gesundheitswesen       Date:  2009-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.